First Time Loading...

Cryo-Cell International Inc
NASDAQ:CCEL

Watchlist Manager
Cryo-Cell International Inc Logo
Cryo-Cell International Inc
NASDAQ:CCEL
Watchlist
Price: 9.09 USD -3.09%
Updated: May 16, 2024
Section:
 

Relative Value

The Relative Value of one CCEL stock under the Base Case scenario is 6.73 USD. Compared to the current market price of 9.09 USD, Cryo-Cell International Inc is Overvalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CCEL Relative Value
Base Case
6.73 USD
Overvaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.4
P/S
P/S
Price to Sales
2.4
vs History
7
vs Industry
45
Median 3Y
1.6
Median 5Y
1.7
Industry
2.4
Forward
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
27
Median 3Y
18.2
Median 5Y
19.3
Industry
23.9
Forward
-45.6
More Details
10.9
P/OCF
P/OCF
Price to OCF
10.9
vs History
1
vs Industry
34
Median 3Y
6.3
Median 5Y
7.3
Industry
15.6
More Details
2 471.5
P/FCFE
P/FCFE
Price to FCFE
2 471.5
vs History
0
vs Industry
0
Median 3Y
25.3
Median 5Y
22.1
Industry
22.5
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-6
Median 5Y
-7.9
Industry
2.3
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
6
vs Industry
42
Median 3Y
1.8
Median 5Y
1.7
Industry
2.5
Forward
2.5
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
7
vs Industry
54
Median 3Y
2.5
Median 5Y
2.5
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
31
Median 3Y
8.8
Median 5Y
8.2
Industry
12.9
Forward
24.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
31
Median 3Y
11.5
Median 5Y
10
Industry
17.8
Forward
141.6
More Details
12
EV/OCF
EV/OCF
Enterprise Value to OCF
12
vs History
0
vs Industry
34
Median 3Y
6.4
Median 5Y
6.8
Industry
15.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
16
Median 3Y
6.5
Median 5Y
8.1
Industry
19.6
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
31
vs Industry
49
Median 3Y
0.9
Median 5Y
1.2
Industry
2
More Details

Multiples Across Competitors

CCEL Competitors Multiples
Cryo-Cell International Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cryo-Cell International Inc
NASDAQ:CCEL
75.4m USD 2.4 -7.7 -6.9 -6.3
US
Cigna Group
XMUN:CGN
90.3B EUR 0.5 27.2 9.8 13
US
Cigna Corp
NYSE:CI
97.2B USD 0.5 26.9 9.7 12.9
US
CVS Health Corp
NYSE:CVS
72.2B USD 0.2 9.8 8.7 8.7
US
Laboratory Corporation of America Holdings
NYSE:LH
18B USD 1.5 41.6 12.5 18.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR 0.7 -27.1 10.2 22.9
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD 1.7 18.6 11 14.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.3B EUR 0.6 24.7 7.1 16.9
DE
Fresenius Medical Care AG
XMUN:FME
12.2B EUR 0.6 24.5 7 16.6
US
DaVita Inc
NYSE:DVA
12.1B USD 1 14.9 8.3 11.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
CCEL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCEL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCEL stock valuation using valuation multiples.
Wall Street Estimates
CCEL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCEL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.